Blotter

Share your thoughts

on remote study sections

Are you serving on a grant-review panel from afar? We want to know how your experience is going
Benjamin Corb
March 25, 2020

The COVID-19 pandemic has forced federal agencies that fund scientific research to move their grant-application review panels online. The National Institutes of Health and the National Science Foundation have used remote study sections in the past, and the ASBMB public affairs office heard mixed reviews about those endeavors. Now that the need for social distancing has resulted in widespread adoption of remote grant-application review, we feel it’s important to record reviewers’ experiences contemporaneously and then, at a later date, share those comments with funding agencies so that the remote-review process can be optimized.

We invite you to use this simple form to share your thoughts on your remote study section experience. 

Here are some of the questions we have, but don’t feel bound to them. We welcome any and all comments about your experiences.

  • Do you think the quality of review will change as a result of remote interactions?  How so?
  • Do you think remote participants are more or less likely to contribute to discussions?  Why?
  • What is lost by not having face-to-face interactions? 
  • What is gained?

We intend to share your comments with both the scientific community and federal agencies. We also hope to develop recommendations for improving remote grant review.

We hope you will take a few minutes to share your thoughts, and we strongly encourage you to share this platform with your colleagues of all disciplines.

Together, we can help the community in a time of need.

Benjamin Corb

Benjamin Corb is director of public affairs at ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Policy

Policy highlights or most popular articles

Why hoarding of hydroxychloroquine needs to stop
News

Why hoarding of hydroxychloroquine needs to stop

March 28, 2020

Some old antimalarial drugs are becoming harder to get in the United States, partly because President Donald Trump has touted them as a potential treatment for COVID-19.

FIRM Act would require some foreign scientists to register as foreign agents
Blotter

FIRM Act would require some foreign scientists to register as foreign agents

March 12, 2020

If enacted, this legislation would affect some foreign scientists collaborating with U.S. scientists on federally funded research.

Lawmakers press FBI and NIH  on research-integrity investigations
Blotter

Lawmakers press FBI and NIH on research-integrity investigations

February 26, 2020

U.S. Reps. Jamie Raskin, D-Md., and Judy Chu, D-Calif., sent the NIH and FBI letters asking about the agencies’ investigations into scientists with ties to China.

Congress passes, considers bills promoting diversity in STEM
Blotter

Congress passes, considers bills promoting diversity in STEM

February 19, 2020

The Building Blocks of STEM Act creates and expands STEM education initiatives at the National Science Foundation. Other pending legislation would boost minority-serving institutions.

Meet Sarina Neote
Blotter

Meet Sarina Neote

February 19, 2020

As the ASBMB’s science policy manager, she advocates for policies that strengthen the scientific workforce and promote an inclusive environment that is supportive of discovery.

Sexual harassment working group releases report
Diversity

Sexual harassment working group releases report

February 12, 2020

An NIH group proposes policy changes covering themes of increased transparency, restorative justice and inclusive work environments.